Covid-19: Testing issues could sink plans to reopen the country. Might CT scans help?

A big part of the plan in getting the country ready to reopen for business is rapid testing for Covid-19: to ensure people are no longer sick and quickly quarantine those who are. But the current tests miss up to 30% of infected people. Increasingly, doctors are calling for CT scans to fill the gap. Although they are more expensive, CT scans can be more reliably and widely used to identify the telltale "ground glass" spots of Covid-19 in infected lungs. STAT's Sharon Begley has more. 

• In response to President Trump's announcement that the U.S. intends to halt funding to the WHO, agency Director-General Tedros Adhanom Ghebreyesus expressed "regret," but emphasized the need for a united front in the face of the pandemic. “When we are divided, the coronavirus exploits the cracks between us,” he told reporters. At the same time, CDC Director Robert Redfield pointedly refrained from criticizing the WHO during an appearance on "Good Morning America," saying that the two health agencies have a productive relationship and that they "continue to have that." 
• In addition to the host of symptoms that Covid-19 patients are known to experience, physicians are now also seeing that some patients develop widespread blood clots in their lungs. STAT's Elizabeth Cooney has more here. 
• Researchers at the University of California, San Francisco, and Mammoth Biosciences just published work describing how the gene editing tool CRISPR could be used to quickly identify the novel coronavirus in throat or nose swab samples. 
• In a new STAT First Opinion, psychiatrist Jessica Gold stresses the importance of protecting and amplifying the voices of the health care workers who are taking to social media to share painful stories of their experiences on the frontlines of the pandemic. 
• The Bill and Melinda Gates Foundation announced that it was upping the funding it was donating to fighting Covid-19, from $105 million to more than $250 million to fund the development of diagnostics, vaccines, and therapies, and new efforts in Africa and South Asia.